Below are the earnings highlights for Iterum Therapeutics plc (ITRM):
Earnings: -$6.582 million in Q4 vs. -$12.362 million in the same period last year.
EPS: $0.25 in Q4 vs. $0.94 in the same period last year.
Excluding items, Iterum Therapeutics plc reported adjusted earnings of -$3.140 million or $0.12 per share for the period.
For comments and feedback: editorial@rttnews.com